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This study was undertaken in an attempt to evaluate the action,
in vitro, of the sulfonamide derivatives now in clinical use on strains
of microorganisms freshly isolated from patients. While consider-
able data are to be found in the literature on this subject, few
complete growth curves comparing the action of all the common
derivatives on a single organism are presented.
Review of the reported work in this field discloses results which are in
part contradictory, possibly due to the employment of various methods and to
differences in media used. The data on each organism with which this paper
deals are presented separately.
Pneumococci.-Lawrence,6 using a peptone broth, found that sulfathia-
zole and its derivatives (phenyl- and methyl-) exerted a much greater
bacteriostatic effect on Types I, II, and III pneumococci than did either sulfa-
pyridine or sulfanilamide. The action of the drugs was purely bacteriostatic
rather than bactericidal, probably due to the large number of organisms in
the original inoculum. Lowell, Strauss, and Finland9 tested 45 strains
recently isolated from patients and found that half of them showed a "slightly
greater susceptibility" to sulfathiazole than to sulfapyridine. Only one strain
was inhibited more by sulfapyridine than by sulfathiazole. The action of the
drugs was determined by noting the highest concentration at which visible
growth was present at 48 hours, and also by observing the lowest concentra-
tion of drug at which cultures, after incubation for 72 hours, yielded sterile
subcultures on the surface of blood-agar plates. A considerable variation in
response of different strains to the same drug was evident, as has been shown
* From the Department of Internal Medicine, Yale University School of Medi-
cine. Presented in abstract form before the American Federation for Clinical
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by others.'12 17, 19 In a recent communication, Finland et al.3 state that in
most media sulfadiazine was found to be less effective against pneumococci
than was sulfathiazole, but that in a liver infusion medium'3 the two drugs
and sulfapyridine were about equally effective.
Staphylococci.-The confusing results found in the literature concerning
the effect of the drugs on staphylococci in vitro undoubtedly arise from the
use of different media in the tests. Rammelkamp and Keefer,16 using whole
defibrinated blood as culture medium, found that sulfathiazole produced a
greater inhibitory effect than did sulfamethylthiazole or sulfapyridine, the last
drug being the least effective. The maximal effect of sulfathiazole was
obtained with concentration of from 2.5 to 5 mgm. per cent. When small
inocula were used the drug was shown to have a bactericidal effect, but only
a bacteriostatic effect was evident with larger inocula. Other workers (Law-
rence,' Bliss and Long,' and Rake and McKee'5), using broth media con-
taining varying amounts of peptone, reported relatively little bacteriostatic
effect of any of the sulfonamides, even in concentrations as high as 200 mgm.
per cent.
Fleming4 demonstrated that the bacteriostatic and bactericidal activity of
sulfanilamide and of sulfapyridine on a single strain of staphylococcus was far
greater and occurred at much lower concentration of the drug in serum alone
than in broth containing peptone. That this inhibition of the action of the
drugs against staphylococci is due to the presence of peptone in the medium,
even in very small amounts, was shown by Spink.'8 When a simple liver
infusion medium'3 was employed, Finland and his co-workers3 observed that
the bacterioktatic effect of sulfadiazine was somewhat less than that of sulfa-
thiazole but greater than that of sulfapyridine.
Alpha hemolytic streptococci.-Bliss and Long' reported that with one
strain of this particular streptococcus a marked inhibition in growth resulted
when the concentration of sulfanilamide or sulfapyridine in broth was 10
mgm. per cent. In a study of three strains of Streptococcus viridans Brit-
ton2 observed no retardation of growth in sulfanilamide solutions in two
instances but with a third strain sulfanilamide was bacteriostatic in a concen-
tration of 1:1000 and bactericidal in 1:500.
Estimating the effect of the drug by its action on alpha hemolytic strep-
tococci in bone-marrow cultures, Osgood14 showed that sulfathiazole was
more effective than was either sulfapyridine or sulfanilamide. Maegraith and
Vollum,lO using defibrinated blood from which the leukocytes had largely
been removed, found no significant inhibition of growth of three strains of
alpha hemolytic streptococci, even in dilutions of sulfanilamide or sulfapyri-
dine as high as 1:2000. However, the size of the inoculum used by these
workers was very large.
Fr4edlinder's bacillus.-The only report on the activity of the sulfonamides
against this organism in vitro is in a recent paper by Finland and his co-work-
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ers,3 who state that in a synthetic medium sulfadiazine is highly bacteriostatic
against Friedliinder's bacillus Types A and B.
Materials and methods
The medium employed throughout the experiments was a beef-heart
infusion broth containing 1 per cent neopeptone (Bacto) and 0.5 per cent
NaCl. The dextrose content was 0.05 per cent and the pH was 7.4. In
all experiments with each strain a single lot of broth was used throughout. In
the case of pneumococci and alpha hemolytic streptococci, rabbit serum was
added to the broth in the amount of 2 per cent. The drugs used were sul-
fanilamide, sulfadiazine,* sulfapyridine, and sulfathiazole. The drug-con-
taining broths were made up by proper dilution of stock 100 mgm. per cent
solutions.
In each experiment the control and tubes containing 5 cc. of broth plus
each of the sulfonamides, respectively, were inoculated and then incubated
at 37.5° C., estimates of the bacterial population in each tube being. made at
suitable intervals by dilution and plate counts. The inoculum was made by
dilution of a 12- to 24-hour culture, so that the original inoculum contained
between 10 and 10,000 organisms, generally in the neighborhood of 50
to 200.
The strains used were all obtained from patients, in general shortly before
the experiments were run. Only one strain was obtained from a patient
already treated with a sulfonamide, the other strains having been isolated
prior to the institution of chemotherapy. Before the growth curves were run
the strains were grown in broth for several transfers in order to insure an
even and steady growth.
Results
1. Pneumococci.-Ten strains of pneumococci were studied;
six were obtained from the blood, three from the sputum, and one
from the cerebrospinal fluid. Of these, two were Type I, four were
Type III, and therewas one each of Types IV, VIII, XV, and XIX.
In all of these experiments the concentration of the sulfonamides
in the broth was S mgm. per cent.
In Fig. 1, illustrative of the method of study, are shown two
growth curves which represent two widely divergent types of
response to the drugs. This variation in response does not depend
upon type, but on the individual strain of the organism, since the
* The sulfadiazine used in these experiments was furnished by the Lederle
Laboratories, through the courtesy of Dr. David A. Bryce.
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four strains of Type III showed a considerable variation in response,
although the differences were not so marked as those shown by the
two strains illus-
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Fig 1. Growth curves of two strains of pneumococci in control fered in their bac-
broth and in broth containing 5 mgm. per cent concentration of the teriosta activity. sulfonamides. In legend, S.A. sulfanilamide, S.D. sulfadiazine, tic S.P.2sulfapyridine, and S.T.-sulfathiasole. The results of
the study of all
ten strains of pneumococci are presented in Fig. 2. These are spot
graphs, each circle representing a particular strain of pneumococcus,
the results being shown forthe controls and each of the sulfonamides
at varying time intervals. Several facts are apparent from examina-
tion of these graphs. At 8 hours of incubation the values in each
column are more widely spread than at inoculation and the median
value has risen. This indicates that the most effective drug, sul-
fathiazole, does not exert its effect immediately, but allows active
multiplication of the organism before its bactericidal action finally
becomes apparent. At this time it is already evident that sulfanil-
amide has less inhibiting effect on the growth of the pneumococci
than havethe other sulfonamides. By 16 hours the superior growth-
inhibiting effect of sulfathiazole is apparent, and a slight difference
in favor of sulfapyridine over sulfadiazine is present. At 24 and
30 hours of incubation this is more marked, and while sulfathiazole
is bactericidal for the large majority of strains, the other drugs exert a varied and inconstant bacteriostatic and bactericidal action
in decreasing efficiency, in the order--sulfapyridine, sulfadiazine,
sulfanilamide.
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It is of interest that in all 10 strains, not a single viable pneu-
mococcus could be obtained from the sulfathiazole broth tubes when
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the individual experiments were concluded after from 39 to 71 hours
of incubation. The attempt to cultivate the organisms was made by
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FIG. 3. Growth curves of a single strain of pneumococcus; on the left in a 5 mgm. per cent
concentration of all the sulfonamides, and on the right, sulfathiazole in 5 mgm. per cent concentration
and sulfadiazine in 5, 10, and 15 mgm. per cent concentrations are compared.
placing all the remaining broth in a large volume of.blood broth,
so as to dilute the sulfonamide present and allow uninhibited growth
of any organisms.
With one strain, pneumococcus Type VIII (Kunze), which
showed a strikingly different response to the bacteriostatic action of
sulfathiazole and sulfadiazine, an attempt was made to quantitate
this difference.
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that of sulfathia-
zole, it was still far less effective than was the latter drug.
2. Staphylococci.-Three strains of Staphylococcus aureus wereSULFONAMIDES AND BACTERIAL GROWTH
studied in 20 mgm. per cent concentration of the sulfonamides,
exclusive of sulfadiazine. As may be seen in Fig. 4, very little bac-
teriostatic effect ofthe drugs was present, and no one of them appears
to be superior to the others. This response is interesting in view of
the fact that the first and third strains were from patients who
recovered clinically, one from staphylococcal meningitis and the
other from a staphylococcal septicemia.
3. Friedldnder's bacillus.-Two strains of Friedl'ander's bacil-
lus were studied in 10 mgm. per cent concentration of the drugs.
Both were obtained from the sputum; one from a case of pneu-
monia, the other
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'0 mgm. per cent concentration of the sulfonamides. action differed in
the two strains.
4. Alpha hemolytic streptococci.-Four strains (none of which
fermented mannite) of this organism, recently obtained from
patients, were studied in 5 mgm. per cent concentration. All strains
were isolated from blood culture; three were from cases of subacute
bacterial endocarditis, while the fourth strain "Williams" appeared
transiently in the blood in a case of tuberculous pneumonia. Fig. 6
illustrates the results obtained when these organisms were grown
in broth containing the four sulfonamides (strain "Williams" was
not tested with sulfadiazine). It is evident that the strains varied
considerably in their sensitivity to the drugs, and also that in the
three drug-sensitive strains, sulfathiazole exerted the most marked
effect, sulfapyridine somewhat less, sulfadiazine still less, and sul-
fanilamide shoved relatively little or none at all. Strain "Wil-
liams" was run in another experiment in 2 mgm. per cent concen-
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tration and a significant difference in bacteriostatic action between
sulfapyridine and sulfathiazole was noted, the latter being more
effective. In Fig. 7 (strain "Weiner") the effect of the drugs in a
HOUQS HOURS
FIG. 6. Growth curves of four strains of alpha hemolytic streptococci in 5 mgm. per cent
concentration of the sulfonamides.
lower concentration on colony growth in blood agar is shown. There
is a close parallelism of the inhibiting effect of each drug with that
obtained by measurement of the growth curves of the same strain
in broth.
Discussion
Before the results of in vitro studies can be evaluated, it must
be recognized that certain components of media, as well as body
fluids, can inhibit the bacteriostatic action of the sulfonamide drugs.
In the case ofbeta hemolytic streptococci it has been shown by Lock-
wood7 that the presence of small amounts of peptone in the medium
markedly inhibits the bacteriostatic action of sulfanilamide. An
identical drug-inhibiting action of peptone has been demonstrated
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with staphylococci by Spink.'8 That extracts of body tissues and
body fluids contain sulfonamide inhibitors in varying quantities is
known,13 and according to a very recent communication of Finland
and his co-workers,3 a given medium may inhibit the action of
different drugs in varying degrees.
Contrary to these opinions, McIntosh and Whitby" found that
the bacteriostatic action of sulfapyridine against Type I pneumo-
coccus in peptone broth was not different from the action in serum
alone. This is contradicted bythe experiments of Hoyt and Levine,
who demonstrated a marked inhibition of the bacteriostatic action of
sulfapyridine when 2 per cent peptone was added to serum.
In the experiments outlined in the present paper, the medium
employed contained two substances, beef-heart extract and peptone,
shown by McLeod"3 to inhibit the antibacterial action of sulfapyri-
dine. On that account, the superiority demonstrated bysulfathiazole
may be more apparent than real, and may possibly be due only to a
more marked action of the inhibitory substances on the other drugs.
This point deserves further study.
Correlation of our in vitro results with actual clinical results
would be of great interest, but sufficient data are not available to
make this comparison with any degree of accuracy.
Similarly, there is but little experimental evidence in the litera-
ture upon which to make a comparison between in vitro and in vivo
methods. McLean, Rogers, and Fleming"2 found that when two
strains of pneumococci were employed, one of which was very sensi-
tive and the other insensitive to sulfapyridine in vitro, the in vivo
tests (intraperitoneal inoculation of mice) produced results parallel
to those obtained in vitro. Using one strain which had been grown
in broth containing sulfapyridine, andwas, therefore, drug resistant,
and another which was shown in vitro to be drug sensitive, Long
and Bliss8 found that sulfapyridine protected mice against the strain
sensitive in vitro, but did not offer any significant protection against
the resistant strain. Both were shown to be lethal strains. On the
other hand, Schmidt et al.,'7 using three strains of pneumococci, two
ofwhich were refractoryand one sensitive invivo (mice), found that
the results in vitro with sulfapyridine showed correlation with only
one strain, none being evident with the other two.
In conclusion, it maybe stated that in vitro and under the condi-
tions of the experiments outlined in this paper, sulf-athiazole has
been shown to exert the greatest inhibitory effect on the growth of
151152 YALE JOURNAL OF BIOLOGY AND MEDICINE
strains of pneumococci, alpha hemolytic streptococci, and Fried-
liander's bacillus. When a significant difference in growth rate was
present, sulfapyridine had a greater inhibitory effect than sulfa-
diazine, and sulfanilamide had, in general, relatively little effect.
Strains of the same organism varied markedly in their response,
and bactericidal as well as bacteriostatic action of the drugs was
observed.
Summary
1. Data have been presented concerning the response in vitro
of strains of pneumococci, alpha hemolytic streptococci, Friedliand-
er's bacilli, and staphylococci to sulfanilamide, sulfapyridine, sulfa-
diazine, and sulfathiazole.
2. With ten strains of pneumococci, sulfathiazole exerted the
most marked effect on the growth of the bacteria and was followed,
in decreasing order of efficiency, by sulfapyridine, sulfadiazine, and
sulfanilamide.
3. Three strains of Staphylococcus aureus exhibited no altera-
tion of their growth in broth containing the sulfonamides.
4. Four strains of alpha hemolytic streptococci showed wide
variation in response to the drugs, with sulfathiazole being the most
effective. Two strains of Friedlander's bacillus exhibited the same
growth tendencies.
5. A marked variation in response from strain to strain of the
same organism was observed.
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FIG. 7. Alpha hemolytic streptococcus, strain "Weiner." Representative colonies
from blood agar plates containing 0.5 mgm. per cent concentration of the sulfonamides
after 65 brs. of incubation. Magnification X 30.